TaiGen Biotechnology Co., Ltd.

Industry

  • Biotechnology
  • Pharmaceuticals
    • Specialty Pharmaceuticals

Other Names/Subsidiaries

  • TaiGen Biopharmaceuticals
See more in Biomedtracker

Latest on TaiGen Biotechnology Co., Ltd.

Scrip

Roche’s Xofluza Can Reduce Flu Transmission, Giving It Potential Market Boost

 
• By Alaric DeArment

Roche Holding AG ’s Xofluza (baloxavir marboxil) stands to strengthen its position in the influenza treatment market with new data showing it can reduce transmission of the virus among people living i

Scrip

Chinese Firms Up Their Game In Novel Flu Antiviral Development

 
• By Dexter Jie Yan

Chinese drug makers are upping their game in the race to develop a homegrown follower of Shionogi & Co. Ltd. and Roche Holding AG ’s oral influenza antiviral Xofluza (baloxavir marboxil), as Joinc

Scrip

Asia Deal Watch: Maruho Licenses Rights In Japan To GI Innovation’s Allergy Candidate

 
• By Jung Won Shin, Vibha Ravi, Lisa Takagi, and Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Maruho Obtains Rights To GI-301 No

Scrip

Asia Deal Watch: Junshi, Rxilient Form Joint Venture Around Toripalimab

 
• By Dexter Jie Yan, Lisa Takagi, Jung Won Shin, Anju Ghangurde, Joseph Haas, and Ian Haydock

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Junshi Allies With Rxilient On JV